UK CMA accuses Merck of breaking competition law with discount scheme

The UK Competition and Markets Authority (CMA) has accused US pharmaceutical company Merck Sharp& Dohme (MSD) of operating an anti-competitive discount scheme for its medicine Remicade.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news